AU Patent

AU2020316997A1 — Methods of treating or preventing spinal muscular atrophy

Assigned to Biogen MA Inc · Expires 2022-03-10 · 4y expired

What this patent protects

Featured are methods for the treatment or prevention of spinal muscular atrophy. Effective dosage regimens are specified. Biomarkers and kits are also provided.

USPTO Abstract

Featured are methods for the treatment or prevention of spinal muscular atrophy. Effective dosage regimens are specified. Biomarkers and kits are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
AU2020316997A1
Jurisdiction
AU
Classification
—
Expires
2022-03-10
Drug substance claim
No
Drug product claim
No
Assignee
Biogen MA Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.